Taysha Gene Therapies Inc (TSHA)
2.57
-0.01
(-0.39%)
USD |
NASDAQ |
May 03, 16:00
2.45
-0.12
(-4.67%)
Pre-Market: 08:40
Taysha Gene Therapies Debt to Equity Ratio: 0.5406 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.5406 |
| September 30, 2023 | -0.7849 |
| June 30, 2023 | -1.033 |
| Date | Value |
|---|---|
| March 31, 2023 | -2.553 |
| December 31, 2022 | 40.01 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-2.553
Minimum
Mar 2023
40.01
Maximum
Dec 2022
7.235
Average
-0.7849
Median
Sep 2023
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 172.73M |
| Total Liabilities (Quarterly) | 97.79M |
| Shareholders Equity (Quarterly) | 74.94M |
| Current Ratio | 4.077 |
| Net Debt Paydown Yield | -0.14% |